|
|
Application effect of Pediatric Feire Kechuan Oral Liquid combined with Azithromycin in children with mycoplasma pneumonia |
WANG Meiyan1 GU Lei2 CHEN Mengli1 |
1.Department of Pediatrics, Changping District Hospital, Beijing 102200, China;
2.Department of Rehabilitation Treatment, Beijing Xiaotangshan Hospital, Beijing 102200, China |
|
|
Abstract Objective To explore the application effect of Pediatric Feire Kechuan Oral Liquid combined with Azithromycin in children with mycoplasma pneumonia (MPP).Methods A total of 128 children with MPP in Beijing Changping District Hospital from June 2017 to October 2020 were selected as the research objects, and they were divided into the control group (64 cases) and the observation group (64 cases) using the random number table method.The control group was treated with Azithromycin, and the observation group was treated with Pediatric Feire Kechuan Oral Liquid on the basic of the control group.The clinical efficacy, serum inflammatory factor levels, disappearance time of symptoms and signs, and adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 95.31%, which was higher than 84.38% in the control group, with a statistical difference (P<0.05).There was no statistical difference in the levels of serum inflammatory factors between the two groups before treatment(P>0.05).The levels of interleukin-6 (IL-6), C-reactive protein (CRP) and tumor necrosis factor-α (TNF-α)after treatment in the two groups were lower than before treatment, and the IL-6, CRP and TNF-α level of observation group were lower than those of control group, the differences were statistically significant (P<0.05); the cough time,fever time, chest X-ray lesion disappearance time and lung rales disappearance time of observation group were shorter than those of the control group, the differences were statistically significant (P<0.05); there was no statistically significant difference in adverse reactions between the two groups (P>0.05).Conclusion Pediatric Feire Kechuan Oral Liquid combined with Azithromycin treatment can improve the clinical efficacy of children with MPP, reduce serum IL-6,CRP, and TNF-α levels, accelerate the disappearance of clinical symptoms, which is safe and reliable.
|
|
|
|
|
[1] |
韩鹏.小儿豉翘清热颗粒联合阿奇霉素对支原体肺炎患儿机体炎症反应及免疫功能影响研究[J].陕西中医,2019,40(4):424-427.
|
[2] |
王志坤,王建忠,李彤,等.特布他林联合阿奇霉素序贯治疗儿童肺炎支原体肺炎的临床研究[J].河北医科大学学报,2019,40(7):820-824.
|
[3] |
王艳茹,章樱,周琴,等.小儿消积止咳口服液联合阿奇霉素治疗支原体肺炎及对患儿体液免疫功能的影响[J].中华中医药学刊,2019,37(5):1168-1171.
|
[4] |
林文燕.丙种球蛋白联合阿奇霉素治疗支原体肺炎的疗效及安全性[J].山东医药,2018,58(10):81-83.
|
[5] |
王芳,王森,王川.小儿肺热咳喘口服液联合美洛西林钠治疗小儿肺炎的临床研究[J].现代药物与临床,2018,33(7):1664-1667.
|
[6] |
韩颖,蓝常肇,马少杰,等.小儿肺热咳喘口服液联合三联吸入雾化治疗法对哮喘急性发作的影响[J].现代生物医学进展,2020,20(6):1116-1119.
|
[7] |
中华医学会儿科学分会呼吸学组,《中华实用儿科临床杂志》编辑委员会.儿童肺炎支原体肺炎诊治专家共识(2015年版)[J].中华实用儿科临床杂志,2015,30(17):1304-1308.
|
[8] |
林弘睿,万乃君,钱艺,等.小儿肺热咳喘口服液联合阿奇霉素对肺炎支原体肺炎患儿肺功能和炎症因子的影响[J].现代生物医学进展,2019,19(17):3267-3270,3217.
|
[9] |
肖雄,李姝,毛兵.清肺抗炎汤联合阿奇霉素治疗支原体肺炎疗效及对免疫功能影响[J].临床军医杂志,2018,46(1):88-90.
|
[10] |
衣兰霞,朱淑霞.清肺止咳定喘清膏联合阿奇霉素治疗支原体肺炎的临床疗效及对血清炎症因子的影响[J].国际免疫学杂志,2018,41(1):46-49.
|
[11] |
张桂欣.甲泼尼龙联合阿奇霉素序贯疗法治疗儿童难治性肺炎支原体肺炎疗效观察[J].新乡医学院学报,2020,37(10):964-967.
|
[12] |
田恬,赵文静,高颂轶,等.甲泼尼龙联合阿奇霉素治疗儿童肺炎支原体大叶性肺炎的疗效[J].药物评价研究,2018,41(1):126-129.
|
[13] |
吕德,刘雨田.布地奈德联合阿奇霉素治疗小儿支原体感染性肺炎的临床分析[J].中国医药科学,2021,11(2):82-84,94.
|
[14] |
卓艳萍,吉萍,朱玉蓉.特布他林联合阿奇霉素治疗支原体肺炎患儿的疗效及安全性分析[J].中国妇幼保健,2019,34(7):1568-1571.
|
[15] |
王盟,张秀芹,杨静,等.阿奇霉素序贯疗法联合双黄连口服液对支原体肺炎患儿T 淋巴细胞亚群及血清炎症因子水平的影响[J].河北医学,2018,24(6):1013-1017.
|
[16] |
李娟.小儿肺热咳喘口服液联合阿奇霉素治疗儿童支原体肺炎的疗效观察[J].传染 病 信息,2019,32(2):151-153.
|
[17] |
邹姒妮,马战英,李桢,等.阿奇霉素和红霉素对小儿支原体肺炎相关炎症介质及免疫调节状态的效果对比[J].中国医药科学,2021,11(2):102-105.
|
|
|
|